IFN-γ

IFN-γ or Interferon-gamma is a crucial cytokine involved in the immune response against various microbial pathogens, including coronaviruses. It is produced by T cells and natural killer cells and acts on both immune and non-immune cells. IFN-γ plays a pivotal role in the clearance of viral infections by stimulating the immune cells to attack and destroy infected cells. The upregulation of IFN-γ expression is considered an early defense mechanism against viral infections before the adaptive immune response takes over. Studies have shown that IFN-γ has a significant impact on the clinical outcome of coronaviruses, including SARS-CoV-2. Patients who survive SARS-CoV-2 infection have shown higher levels of IFN-γ, indicating that it may play a role in controlling the viral replication and spread. Conversely, patients with severe COVID-19 have shown decreased IFN-γ levels, indicating that it may be a critical indicator in predicting severe cases. IFN-γ has also shown potential as a therapeutic agent against coronaviruses. Several clinical trials have been conducted to evaluate the efficacy of IFN-γ in treating COVID-19 patients. However, the results have been mixed, with some studies showing a significant reduction in the severity of the disease, while others have failed to show any significant benefit. Nevertheless, the potential of IFN-γ as a therapeutic agent against coronaviruses warrants further investigation. In conclusion, IFN-γ is a crucial cytokine involved in the immune response against coronaviruses. Its role in controlling the viral replication and spread, as well as its potential as a therapeutic agent, makes it a significant target for further research. Understanding the mechanisms underlying IFN-γ's action in coronavirus infections may lead to the development of more effective treatments for COVID-19 and other coronavirus diseases.